Morgan Stanley
AGN.PRA

Morgan Stanley’s Allergan plc AGN.PRA Stock Holding History

Morgan Stanley’s Portfolio AGN.PRA Stock Details AGN.PRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-6,924
Closed -$4.06M – 6847
2017
Q4 		$4.06M Sell
6,924
-8,639
-56% -$5.57M ﹤0.01% 3327
2017
Q3 		$11.5M Sell
15,563
-153
-1% -$127K ﹤0.01% 2149
2017
Q2 		$13.6M Sell
15,716
-4,284
-21% -$3.59M ﹤0.01% 1872
2017
Q1 		$16.9M Buy
20,000
+622
+3% +$515K 0.01% 1703
2016
Q4 		$14.8M Sell
19,378
-728
-4% -$550K ﹤0.01% 1837
2016
Q3 		$16.5M Buy
20,106
+765
+4% +$661K 0.01% 1608
2016
Q2 		$16.1M Buy
19,341
+8,371
+76% +$6.99M 0.01% 1590
2016
Q1 		$10M Sell
10,970
-7,469
-41% -$7.14M ﹤0.01% 1864
2015
Q4 		$18.9M Buy
18,439
+649
+4% +$652K 0.01% 1448
2015
Q3 		$16.8M Buy
17,790
+17,731
+30,053% +$18.5M 0.01% 1530
2015
Q2 		$62K Buy
+59
New +$61.8K ﹤0.01% 5780

Other funds holding AGN.PRA

PWS
Peloton Wealth Strategists Indianapolis, Indiana $271M AUM 19.14% 1-Year Est. Return

Morgan Stanley's AGN.PRA Position: Q1 2018 in Review

Morgan Stanley sold out of Allergan plc (AGN.PRA) in Q1 2018, closing a stake of 6,924 shares — an estimated $4.06M sold.

Morgan Stanley first reported a position in AGN.PRA in Q2 2015 and held it in 11 quarters. The position peaked at $18.9M in Q4 2015. 1 fund tracked by Wall St. Rank holds AGN.PRA as of Q1 2018.

  • Morgan Stanley reported no remaining Allergan plc position as of Q1 2018 after selling out during the quarter.
  • Morgan Stanley sold 6,924 Allergan plc shares in Q1 2018, an estimated $4.06M.
  • Morgan Stanley first reported a position in Allergan plc in Q2 2015 and held it in 11 quarters.
  • Morgan Stanley's Allergan plc position peaked at $18.9M in Q4 2015.
  • 1 fund tracked by Wall St. Rank held Allergan plc as of Q1 2018.

Based on Morgan Stanley's 13F filing for Q1 2018, filed 14 May 2018.